These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22767405)

  • 1. Metastatic view of breast cancer.
    Banfalvi G
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):815-22. PubMed ID: 22767405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of parathymic lymph nodes in metastatic tumor development.
    Banfalvi G
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):89-97. PubMed ID: 22134656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic spread of mesenchymal renal tumor to metastatic parathymic lymph nodes in rat.
    Rozsa D; Trencsenyi G; Kertai P; Marian T; Nagy G; Banfalvi G
    Histol Histopathol; 2009 Nov; 24(11):1367-79. PubMed ID: 19760586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic Spread from Abdominal Tumor Cells to Parathymic Lymph Nodes.
    Király G; Hargitai Z; Kovács I; Szemán-Nagy G; Juhász I; Bánfalvi G
    Pathol Oncol Res; 2019 Apr; 25(2):625-633. PubMed ID: 30406399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal capsule-parathymic lymph node complex: a new in vivo metastatic model in rats.
    Trencsenyi G; Kertai P; Bako F; Hunyadi J; Marian T; Hargitai Z; Pocsi I; Muranyi E; Hornyak L; Banfalvi G
    Anticancer Res; 2009 Jun; 29(6):2121-6. PubMed ID: 19528472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
    Camp RL; Rimm EB; Rimm DL
    Cancer; 2000 Jan; 88(1):108-13. PubMed ID: 10618612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic Janus-faced mycotoxins against thoracal and breast metastases.
    Banfalvi G
    Apoptosis; 2023 Jun; 28(5-6):754-768. PubMed ID: 37055605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
    van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems.
    Cho J; Han W; Lee JW; Ko E; Kang SY; Jung SY; Kim EK; Moon WK; Cho N; Park IA; Chung JK; Hwang KT; Kim SW; Noh DY
    Ann Surg Oncol; 2008 Aug; 15(8):2278-86. PubMed ID: 18528729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Internal mammary lymph node invasion in breast cancer: myth or reality?].
    Maalej M; Gargouri W; Kochbati L; Nasr C; Frikha H; Hentati D; Elkadri N; Kraiem T; Chebbi A; Saadi A; Mrad K; Zakhama A; Hechiche M; Ben Romdhane K
    Tunis Med; 2009 May; 87(5):319-22. PubMed ID: 19927761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the mechanisms of lymph node metastasis.
    Nathanson SD
    Cancer; 2003 Jul; 98(2):413-23. PubMed ID: 12872364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
    St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
    Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host-tumor interactions in the progression of breast cancer metastasis.
    Price JE
    In Vivo; 1994; 8(1):145-54. PubMed ID: 8054504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of sentinel lymphadenectomy in breast cancer.
    Giuliano AE
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):52S-55S. PubMed ID: 11599900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time imaging of lymphogenic metastasis in orthotopic human breast cancer.
    Dadiani M; Kalchenko V; Yosepovich A; Margalit R; Hassid Y; Degani H; Seger D
    Cancer Res; 2006 Aug; 66(16):8037-41. PubMed ID: 16912179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.